| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.13B | 7.83B | 8.16B | 8.55B | 8.42B | 8.05B |
| Gross Profit | 4.53B | 4.54B | 4.69B | 4.89B | 4.70B | 4.53B |
| EBITDA | 1.29B | 1.21B | 1.33B | 1.37B | 1.53B | 1.06B |
| Net Income | 756.00M | 625.00M | 733.00M | 533.00M | 755.00M | 422.00M |
Balance Sheet | ||||||
| Total Assets | 25.61B | 26.75B | 25.72B | 25.60B | 24.61B | 24.26B |
| Cash, Cash Equivalents and Short-Term Investments | 10.61B | 9.83B | 10.72B | 10.80B | 10.67B | 10.48B |
| Total Debt | 380.00M | 380.00M | 380.00M | 480.00M | 480.00M | 530.00M |
| Total Liabilities | 3.20B | 3.62B | 3.24B | 3.70B | 3.52B | 3.19B |
| Stockholders Equity | 22.41B | 23.12B | 22.48B | 21.91B | 21.08B | 21.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.03B | 548.00M | 688.00M | 1.13B | 273.00M |
| Operating Cash Flow | 0.00 | 1.51B | 880.00M | 997.00M | 1.54B | 1.02B |
| Investing Cash Flow | 0.00 | -2.05B | -575.00M | -416.00M | -404.00M | -765.00M |
| Financing Cash Flow | 0.00 | -356.00M | -387.00M | -449.00M | -946.00M | -248.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥139.59B | -575.87 | 11.70% | 3.59% | 3.84% | -1.90% | |
74 Outperform | ¥19.77B | 29.31 | ― | 1.99% | -3.95% | -14.59% | |
63 Neutral | ¥37.29B | 3.05 | ― | 5.23% | -3.43% | 6.93% | |
62 Neutral | ¥67.70B | 30.91 | 18.28% | 6.12% | 6.69% | -72.72% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥227.35B | 15.12 | 5.31% | 2.29% | -1.37% | 104.77% | |
54 Neutral | ¥108.17B | 233.67 | 2.80% | 3.38% | -4.52% | -91.68% |